Stockreport

enGene to Host Conference Call to Provide Update on Pivotal Cohort of LEGEND Trial

enGene Holdings Inc.  (ENGN) 
PDF BOSTON & MONTREAL--(BUSINESS WIRE)--enGene Holdings Inc. (Nasdaq: ENGN or “enGene” or the “Company”), a clinical-stage, non-viral genetic medicines company, today an [Read more]